Takeda Pharmaceutical proposes $62bn acquisition of Shire to expand rare disease capabilities
Takeda Pharmaceutical, a major Japanese pharmaceutical company, has made a $62 billion offer to acquire Shire, an Ireland-based leader in rare disease treatments. This proposal, ... Read More
Allergan announces job cuts as part of cost-reduction strategy
Allergan, globally recognized for its Botox cosmetic injections, has revealed plans to eliminate more than 1,000 jobs across its operations. This move is part of ... Read More